Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDP-123 Lotion vs Tazorac Cream in Acne Vulgaris
NCT02525822Phase 2Unknown
- Sponsor
- Bausch Health
- Start
- Sep 2015
- Primary completion
- Jun 2016
01
Overview
A Phase 2 trial of tazarotene in acne vulgaris, sponsored by Bausch Health. Status: unknown.
02
Drugs
tazarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02525822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02525822.